← Open Payments lookup

KELLY LONDON: Open Payments

NPI 1376913178 · ARLINGTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$588 in 28 payments from 10 companies in 2025. Trend: 2023 $4,105 · 2024 $1,449 · 2025 $588

Food & beverage: $588
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$188
Otsuka America Pharmaceutical, Inc.3$72
Takeda Pharmaceuticals U.S.A., Inc.3$72
Lundbeck LLC2$53
Bausch Health US, LLC3$49
Vanda Pharmaceuticals Inc.2$43
Tris Pharma Inc2$38
Axsome Therapeutics, Inc.1$29
ABBVIE INC.1$28
Supernus Pharmaceuticals, Inc.1$15

Products named: CAPLYTA, REXULTI, TRINTELLIX, APLENZIN, Dyanavel XR, Auvelity, VRAYLAR, HETLIOZ.

Industry payments across VA — which companies pay providers there.